Home › Employers › Immunova Therapeutics
Immunova Therapeutics: H-1B salaries and sponsorship
Immunova Therapeutics filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 2. Median offered salary: $119,038.
Does Immunova Therapeutics sponsor H-1B visas?
Immunova Therapeutics filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 1, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Scientist | 3 | $119,038 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $110,947 |
| FY2026 | 1 | $127,130 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Scientist | $127,130–$127,192 Level IV | Monrovia, CA | Apr 1, 2026 | Oct 1, 2026 | Certified |
| Scientist | $110,947–$110,989 Level IV | Monrovia, CA | May 2, 2023 | Oct 1, 2023 | Certified |
| Scientist | $111,000–$130,000 Level IV | Monrovia, CA | Jan 5, 2023 | Jul 5, 2023 | Withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).